• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hemodialysis for removal of dabigatran in a patient with gastric hemorrhage.采用血液透析清除一名胃出血患者体内的达比加群。
Acute Med Surg. 2015 Jun 30;3(2):132-134. doi: 10.1002/ams2.123. eCollection 2016 Apr.
2
Safe use of hemodialysis for dabigatran removal before cardiac surgery.心脏手术前使用血液透析清除达比加群的安全性。
Ann Pharmacother. 2012 Sep;46(9):e21. doi: 10.1345/aph.1R081. Epub 2012 Aug 7.
3
What is the role of hemodialysis for dabigatran-associated major bleeding?
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):514-7. doi: 10.1182/asheducation-2014.1.514. Epub 2014 Nov 18.
4
Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.达比加群酯——一种新型、可逆、口服直接凝血酶抑制剂:凝血检测的解读及其抗凝活性的逆转。
Thromb Haemost. 2010 Jun;103(6):1116-27. doi: 10.1160/TH09-11-0758. Epub 2010 Mar 29.
5
Management of Dabigatran-Associated Bleeding with Two Doses of Idarucizumab Plus Hemodialysis.两剂艾达司珠单抗联合血液透析治疗达比加群相关出血
Pharmacotherapy. 2016 Oct;36(10):e160-e165. doi: 10.1002/phar.1830. Epub 2016 Sep 25.
6
Rectal bleeding and hemostatic disorders induced by dabigatran etexilate in 2 elderly patients.达比加群酯致2例老年患者直肠出血及止血障碍
Ann Pharmacother. 2012 Jun;46(6):e14. doi: 10.1345/aph.1Q705. Epub 2012 Jun 5.
7
Management of dabigatran-associated intracerebral and intraventricular hemorrhage: a case report.达比加群相关性脑内和脑室内出血的管理:一例报告
J Emerg Med. 2014 Apr;46(4):525-9. doi: 10.1016/j.jemermed.2013.11.097. Epub 2014 Feb 6.
8
Reversal of dabigatran requiring hemodialysis, fresh frozen plasma, and 2 doses of idarucizumab in a patient with acute kidney injury.一名急性肾损伤患者需要行血液透析、新鲜冰冻血浆及 2 剂依达鲁珠单抗来逆转达比加群。
Am J Health Syst Pharm. 2019 Jan 1;76(1):9-12. doi: 10.1093/ajhp/zxy008.
9
A novel coagulation parameter monitoring bleeding tendency of Chinese nonvalvular atrial fibrillation patients prescribing dabigatran etexilate.一种监测服用达比加群酯的中国非瓣膜性心房颤动患者出血倾向的新型凝血参数。
Blood Coagul Fibrinolysis. 2016 Jul;27(5):563-7. doi: 10.1097/MBC.0000000000000467.
10
Hemopericardium in a patient treated with dabigatran etexilate.达比加群酯治疗患者发生的心包积血。
Pharmacotherapy. 2012 May;32(5):e103-7. doi: 10.1002/j.1875-9114.2012.01036.x. Epub 2012 Apr 9.

引用本文的文献

1
An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants.非维生素K拮抗剂口服抗凝剂的逆转最新进展
Adv Hematol. 2020 Jan 27;2020:7636104. doi: 10.1155/2020/7636104. eCollection 2020.

本文引用的文献

1
Dabigatran etexilate: a review of its use in the treatment of acute venous thromboembolism and prevention of venous thromboembolism recurrence.达比加群酯:用于治疗急性静脉血栓栓塞和预防静脉血栓栓塞复发的研究进展。
Drugs. 2014 Oct;74(15):1785-800. doi: 10.1007/s40265-014-0304-7.
2
The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.达比加群酯治疗患者的出血、手术和过量的急性处理。
Emerg Med J. 2014 Feb;31(2):163-8. doi: 10.1136/emermed-2012-201976. Epub 2013 Feb 22.
3
Removal of dabigatran by hemodialysis.血液透析清除达比加群。
Am J Kidney Dis. 2013 Mar;61(3):487-9. doi: 10.1053/j.ajkd.2012.08.047. Epub 2012 Dec 5.
4
Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants.新一代口服抗凝剂抗凝效果的实验室评估。
J Thromb Haemost. 2013 Feb;11(2):245-52. doi: 10.1111/jth.12096.
5
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.在健康受试者中,用凝血酶原复合物浓缩物逆转利伐沙班和达比加群:一项随机、安慰剂对照、交叉研究。
Circulation. 2011 Oct 4;124(14):1573-9. doi: 10.1161/CIRCULATIONAHA.111.029017. Epub 2011 Sep 6.
6
Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.达比加群酯——一种新型、可逆、口服直接凝血酶抑制剂:凝血检测的解读及其抗凝活性的逆转。
Thromb Haemost. 2010 Jun;103(6):1116-27. doi: 10.1160/TH09-11-0758. Epub 2010 Mar 29.
7
Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study.肾功能损害对口服达比加群酯的药代动力学和药效学的影响:一项开放标签、平行组、单中心研究。
Clin Pharmacokinet. 2010 Apr;49(4):259-68. doi: 10.2165/11318170-000000000-00000.
8
Dabigatran versus warfarin in patients with atrial fibrillation.达比加群与华法林用于房颤患者的比较。
N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30.
9
Markers of increased thrombin generation.凝血酶生成增加的标志物。
Ric Clin Lab. 1990 Oct-Dec;20(4):217-25. doi: 10.1007/BF02900706.

采用血液透析清除一名胃出血患者体内的达比加群。

Hemodialysis for removal of dabigatran in a patient with gastric hemorrhage.

作者信息

Kashiura Masahiro, Fujita Hiroshi, Sugiyama Kazuhiro, Akashi Akiko, Hamabe Yuichi

机构信息

Tertiary Emergency Medical Center Tokyo Metropolitan Bokutoh Hospital Tokyo Japan.

Department of Transfusion Medicine Tokyo Metropolitan Bokutoh Hospital Tokyo Japan.

出版信息

Acute Med Surg. 2015 Jun 30;3(2):132-134. doi: 10.1002/ams2.123. eCollection 2016 Apr.

DOI:10.1002/ams2.123
PMID:29123765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5667362/
Abstract

CASE

An 82-year-old man taking dabigatran was admitted with syncope. Computed tomography showed extravasation from the stomach. Laboratory data revealed renal insufficiency and prolonged activated partial thromboplastin time. The gastric endoscopy showed a gastric ulcer with an exposed vessel. However, an endoscopic hemostatic procedure failed to completely stop the bleeding. The patient experienced cardiac arrest from hypotensive shock. Spontaneous circulation returned after 5 min of resuscitation. After endoscopy, computed tomography showed a gastric perforation. For dabigatran removal, the patient underwent a 6-h hemodialysis session. Thrombin activity and thrombin-antithrombin complex increased during hemodialysis, while activated partial thromboplastin time decreased.

OUTCOME

Good recovery was observed after dialysis and the following gastrectomy.

CONCLUSION

Hemodialysis should be considered for dabigatran removal in cases of life-threatening hemorrhage. The thrombin-antithrombin complex may be useful for monitoring the plasma dabigatran level.

摘要

病例

一名82岁正在服用达比加群的男性因晕厥入院。计算机断层扫描显示胃有外渗。实验室数据显示肾功能不全及活化部分凝血活酶时间延长。胃镜检查显示胃溃疡且有血管外露。然而,内镜止血操作未能完全止血。患者因低血压性休克发生心脏骤停。复苏5分钟后恢复自主循环。内镜检查后,计算机断层扫描显示胃穿孔。为清除达比加群,患者接受了6小时的血液透析治疗。血液透析期间凝血酶活性及凝血酶 - 抗凝血酶复合物升高,而活化部分凝血活酶时间降低。

转归

透析及随后的胃切除术后恢复良好。

结论

在危及生命的出血情况下,应考虑进行血液透析以清除达比加群。凝血酶 - 抗凝血酶复合物可能有助于监测血浆达比加群水平。